OBJECTIVE: Depression occurs more commonly during the menopausal transition in women with vasomotor symptoms (VMS) than in those without, but most women with VMS do not develop depression. It has been hypothesized that VMS are associated with depression because VMS lead to repeated awakenings, which impair daytime well-being. We aimed to determine if objectively measured sleep and perceived sleep quality are worse in depressed women with VMS than in nondepressed women with VMS. METHODS: Objectively and subjectively measured sleep parameters were compared between 52 depressed women with VMS and 51 nondepressed controls with VMS. Actigraphic measures of objective sleep conducted in the home environment and subjective measures of sleep quality (Pittsburgh Sleep Questionnaire Index) were compared using linear regression models. RESULTS: On objective assessments, depressed women with VMS spent less time in bed (by 64.8 min; P < 0.001) and had shorter total sleep time (by 47.7 min; P = 0.008), longer sleep-onset latency (by 13.8 min; P = 0.03), and lower sleep efficiency (by 3.2 percentage points; P = 0.09), but did not awaken more or spend more time awake after sleep onset than nondepressed controls with VMS. Depressed women also reported worse sleep quality (mean Pittsburgh Sleep Questionnaire Index 12.0 vs 8.3; P < 0.001). Adjustment for VMS frequency and important demographic characteristics did not alter these associations. CONCLUSIONS: Sleep quality and selected parameters of objectively measured sleep, but not sleep interruption, are worse in depressed than in nondepressed women with VMS. The type of sleep disturbance seen in depressed participants was not consistent with the etiology of depression secondary to VMS-associated awakenings.
OBJECTIVE:Depression occurs more commonly during the menopausal transition in women with vasomotor symptoms (VMS) than in those without, but most women with VMS do not develop depression. It has been hypothesized that VMS are associated with depression because VMS lead to repeated awakenings, which impair daytime well-being. We aimed to determine if objectively measured sleep and perceived sleep quality are worse in depressedwomen with VMS than in nondepressed women with VMS. METHODS: Objectively and subjectively measured sleep parameters were compared between 52 depressedwomen with VMS and 51 nondepressed controls with VMS. Actigraphic measures of objective sleep conducted in the home environment and subjective measures of sleep quality (Pittsburgh Sleep Questionnaire Index) were compared using linear regression models. RESULTS: On objective assessments, depressedwomen with VMS spent less time in bed (by 64.8 min; P < 0.001) and had shorter total sleep time (by 47.7 min; P = 0.008), longer sleep-onset latency (by 13.8 min; P = 0.03), and lower sleep efficiency (by 3.2 percentage points; P = 0.09), but did not awaken more or spend more time awake after sleep onset than nondepressed controls with VMS. Depressedwomen also reported worse sleep quality (mean Pittsburgh Sleep Questionnaire Index 12.0 vs 8.3; P < 0.001). Adjustment for VMS frequency and important demographic characteristics did not alter these associations. CONCLUSIONS: Sleep quality and selected parameters of objectively measured sleep, but not sleep interruption, are worse in depressed than in nondepressed women with VMS. The type of sleep disturbance seen in depressedparticipants was not consistent with the etiology of depression secondary to VMS-associated awakenings.
Authors: Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews Journal: Am J Public Health Date: 2006-05-30 Impact factor: 9.308
Authors: Howard M Kravitz; Patricia A Ganz; Joyce Bromberger; Lynda H Powell; Kim Sutton-Tyrrell; Peter M Meyer Journal: Menopause Date: 2003 Jan-Feb Impact factor: 2.953
Authors: Howard M Kravitz; Elizabeth Avery; Maryfran Sowers; Joyce T Bromberger; Jane F Owens; Karen A Matthews; Martica Hall; Huiyong Zheng; Ellen B Gold; Daniel J Buysse Journal: Sleep Date: 2011-09-01 Impact factor: 5.849
Authors: Nanette Santoro; Amanda Allshouse; Genevieve Neal-Perry; Lubna Pal; Rogerio A Lobo; Frederick Naftolin; Dennis M Black; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; N Maritza Dowling; Mary Dunn; Carey E Gleason; Howard N Hodis; Barbara Isaac; Maureen Magnani; JoAnn E Manson; Virginia M Miller; Hugh S Taylor; Whitney Wharton; Erin Wolff; Viola Zepeda; S Mitchell Harman Journal: Menopause Date: 2017-03 Impact factor: 2.953